Erlotinib and Chemotherapy for 2nd Line Treatment (Tx) of Metastatic Colorectal Cancer (mCRC)

Stopped Terminated due to poor enrollment and grade 3 toxicities noted during an interim analysis.

Conditions

• Metastatic Colorectal Cancer

Interventions

• DRUG: Erlotinib
• DRUG: Fluorouracil
• DRUG: Leucovorin
• DRUG: Oxaliplatin
• DRUG: Irinotecan

Sponsor

OHSU Knight Cancer Institute

Collaborators

• [object Object]
• [object Object]